Boothbay Fund Management, LLC Magenta Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $98,642 - $185,484	-22,267 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $62,721 - $102,193	10,333 Added 86.58%	22,267 $162,000
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $116,475 - $168,866	11,934 New	11,934 $117,000
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $119,894 - $209,423	-15,652 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.1 - $7.94 $95,477 - $124,276	15,652 New	15,652 $123,000

Q3 2019 Nov 14, 2019	SELL	$9.63 - $14.0 $198,695 - $288,862	-20,633 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $276,482 - $364,585	20,633 New	20,633 $304,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.